High neutrophil counts are associated with the release of pro-tumor substances such as reactive oxygen species, arginase, inflammatory cytokines, tumor or vascular growth factors, and metalloproteinases, while low lymphocyte counts are associated with impaired anti-tumor response, CD8+ T cell cytotoxicity, and CD4+ helper T cell function (42–44). The gene discussed is CD4; the disease is neoplasm.